HomeSCPI • IDX
add
Organon Pharma Indonesia Tbk PT
Market news
Financials
Income Statement
Revenue
Net income
| (IDR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 1.21T | 89.50% |
Operating expense | 19.67B | -11.13% |
Net income | 52.72B | 694.10% |
Net profit margin | 4.34 | 317.31% |
Earnings per share | — | — |
EBITDA | 78.50B | 663.31% |
Effective tax rate | 27.51% | — |
Balance Sheet
Total assets
Total liabilities
| (IDR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 284.93B | 149.53% |
Total assets | 2.28T | 39.14% |
Total liabilities | 945.26B | 56.77% |
Total equity | 1.33T | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | 7.87% | — |
Return on capital | 13.34% | — |
Cash Flow
Net change in cash
| (IDR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 52.72B | 694.10% |
Cash from operations | 39.69B | 285.10% |
Cash from investing | -9.92B | -192.74% |
Cash from financing | -563.34M | -226.97% |
Net change in cash | 20.66B | 272.34% |
Free cash flow | -29.61B | -2,156.51% |
About
Founded
1972
Website
Employees
178
